Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

ClinicalTrials.gov ID: NCT00996580

Public ClinicalTrials.gov record NCT00996580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of a Combination Oral Contraceptive Regimen (DR-103) for the Prevention of Pregnancy in Women

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label, single-treatment study. All subjects will receive 12 months of oral contraceptive therapy with DR-103. Study participants will receive physical and gynecological exams, including Pap smear. During the study, all participants will be required to complete a diary.

Study identification

NCT ID
NCT00996580
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Teva Women's Health
Industry
Enrollment
3,597 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 40 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2009 (Type not available)
Primary completion
Sep 2011 (Actual)
Completion
Sep 2011 (Actual)
Last update posted
Jun 24, 2013

2009 – 2011

United States locations

U.S. sites
94
U.S. states
31
U.S. cities
86
Facility City State ZIP Site status
Teva Women's Health Research Investigational Site Montgomery Alabama 36116 —
Teva Women's Health Research Investigational Site Phoenix Arizona 85015 —
Teva Women's Health Research Investigational Site Phoenix Arizona 85037 —
Teva Women's Health Research Investigational Site Tucson Arizona 85741 —
Teva Women's Health Research Investigational Site Little Rock Arkansas 72205 —
Teva Women's Health Research Investigational Site Anaheim California 92801 —
Teva Women's Health Research Investigational Site Irvine California 92618 —
Teva Women's Health Research Investigational Site Los Angeles California 90033 —
Teva Women's Health Research Investigational Site National City California 91950 —
Teva Women's Health Research Investigational Site San Diego California 29103 —
Teva Women's Health Research Investigational Site San Diego California 92108 —
Teva Women's Health Research Investigational Site San Diego California 92123 —
Teva Women's Health Research Investigational Site San Francisco California 92103 —
Teva Women's Health Research Investigational Site Torrance California 90502 —
Teva Women's Health Research Investigational Site Colorado Springs Colorado 80909 —
Teva Women's Health Research Investigational Site Pueblo Colorado 81001 —
Teva Women's Health Research Investigational Site Washington D.C. District of Columbia 20036 —
Teva Women's Health Research Investigational Site Clearwater Florida 33759 —
Teva Women's Health Research Investigational Site Jacksonville Florida 32207 —
Teva Women's Health Research Investigational Site Leesburg Florida 34748 —
Teva Women's Health Research Investigational Site Miami Florida 33143 —
Teva Women's Health Research Investigational Site Miami Florida 33186 —
Teva Women's Health Research Investigational Site New Port Richey Florida 34652 —
Teva Women's Health Research Investigational Site Palm Beach Florida 33409 —
Teva Women's Health Research Investigational Site St. Petersburg Florida 33709 —
Teva Women's Health Research Investigational Site Tampa Florida 33613 —
Teva Women's Health Research Investigational Site West Palm Beach Florida 33401 —
Teva Women's Health Research Investigational Site Atlanta Georgia 30303 —
Teva Women's Health Research Investigational Site Decatur Georgia 30034 —
Teva Women's Health Research Investigational Site Roswell Georgia 30075 —
Teva Women's Health Research Investigational Site Sandy Springs Georgia 30328 —
Teva Women's Health Research Investigational Site Savannah Georgia 31406 —
Teva Women's Health Research Investigational Site Meridian Idaho 83642 —
Teva Women's Health Research Investigational Site Champaign Illinois 61820 —
Teva Women's Health Research Investigational Site Wichita Kansas 67207 —
Teva Women's Health Research Investigational Site Lexington Kentucky 40509 —
Teva Women's Health Research Investigational Site Louisville Kentucky 40291 —
Teva Women's Health Research Investigational Site Mount Sterling Kentucky 40353 —
Teva Women's Health Research Investigational Site Baton Rouge Louisiana 70808 —
Teva Women's Health Research Investigational Site Metairie Louisiana 70006 —
Teva Women's Health Research Investigational Site Baltimore Maryland 21201 —
Teva Women's Health Research Investigational Site Kansas City Missouri 64108 —
Teva Women's Health Research Investigational Site St Louis Missouri 63117 —
Teva Women's Health Research Investigational Site Lincoln Nebraska 68510 —
Teva Women's Health Research Investigational Site Las Vegas Nevada 89146 —
Teva Women's Health Research Investigational Site Berlin New Jersey 08009 —
Teva Women's Health Research Investigational Site Lawrenceville New Jersey 08648 —
Teva Women's Health Research Investigational Site Moorestown New Jersey 08057 —
Teva Women's Health Research Investigational Site New Brunswick New Jersey 08901 —
Teva Women's Health Research Investigational Site Albuquerque New Mexico 87102 —
Teva Women's Health Research Investigational Site Port Jefferson New York 11777 —
Teva Women's Health Research Investigational Site Rochester New York 14609 —
Teva Women's Health Research Investigational Site Cary North Carolina 27518 —
Teva Women's Health Research Investigational Site Charlotte North Carolina 28209 —
Teva Women's Health Research Investigational Site New Bern North Carolina 28562 —
Teva Women's Health Research Investigational Site Raleigh North Carolina 27609 —
Teva Women's Health Research Investigational Site Raleigh North Carolina 27612 —
Teva Women's Health Research Investigational Site Salisbury North Carolina 28144 —
Teva Women's Health Research Investigational Site Wilmington North Carolina 28401 —
Teva Women's Health Research Investigational Site Winston-Salem North Carolina 27103 —
Teva Women's Health Research Investigational Site Columbus Ohio 43210 —
Teva Women's Health Research Investigational Site Columbus Ohio 43213 —
Teva Women's Health Research Investigational Site Edmond Oklahoma 73013 —
Teva Women's Health Research Investigational Site Oklahoma City Oklahoma 73112 —
Teva Women's Health Research Investigational Site Eugene Oregon 97401 —
Teva Women's Health Research Investigational Site Medford Oregon 97504 —
Teva Women's Health Research Investigational Site Philadelphia Pennsylvania 19114 —
Teva Women's Health Research Investigational Site Pittsburgh Pennsylvania 15206 —
Teva Women's Health Research Investigational Site Charleston South Carolina 29425 —
Teva Women's Health Research Investigational Site Columbia South Carolina 29201 —
Teva Women's Health Research Investigational Site Goose Creek South Carolina 29445 —
Teva Women's Health Research Investigational Site Greenville South Carolina 29605 —
Teva Women's Health Research Investigational Site Greer South Carolina 29651 —
Teva Women's Health Research Investigational Site Hilton Head Island South Carolina 29926 —
Teva Women's Health Research Investigational Site Bristol Tennessee 37620 —
Teva Women's Health Research Investigational Site Jackson Tennessee 38305 —
Teva Women's Health Research Investigational Site Knoxville Tennessee 37920 —
Teva Women's Health Research Investigational Site Memphis Tennessee 38120 —
Teva Women's Health Research Investigational Site Nashville Tennessee 37203 —
Teva Women's Health Research Investigational Site Austin Texas 78759 —
Teva Women's Health Research Investigational Site Dallas Texas 75234 —
Teva Women's Health Research Investigational Site Dallas Texas 75390 —
Teva Women's Health Research Investigational Site Fort Worth Texas 76135 —
Teva Women's Health Research Investigational Site Houston Texas 77054 —
Teva Women's Health Research Investigational Site San Antonio Texas 78229 —
Teva Women's Health Research Investigational Site Waco Texas 76712 —
Teva Women's Health Research Investigational Site Salt Lake City Utah 84107 —
Teva Women's Health Research Investigational Site Arlington Virginia 22203 —
Teva Women's Health Research Investigational Site Newport News Virginia 23602 —
Teva Women's Health Research Investigational Site Norfolk Virginia 23502 —
Teva Women's Health Research Investigational Site Norfolk Virginia 23507 —
Teva Women's Health Research Investigational Site Richmond Virginia 23233 —
Teva Women's Health Research Investigational Site Seattle Washington 98105 —
Teva Women's Health Research Investigational Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00996580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2013 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00996580 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →